Report Detail
Global Interferon Alpha-2a Biosimilar Market Growth 2019-2024
- RnM2906553 |
- 08 February, 2019 |
- Global |
- 133 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.
Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%.
Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017.
South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%.
Market competition is not intense. Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Interferon Alpha-2a Biosimilar market will register a -11.2% CAGR in terms of revenue, the global market size will reach US$ 190 million by 2024, from US$ 390 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interferon Alpha-2a Biosimilar business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Interferon Alpha-2a Biosimilar market by product type, application, key manufacturers and key regions and countries.
This study considers the Interferon Alpha-2a Biosimilar value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Long-lasting Type
Ordinary Type
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hepatitis C
Hepatitis B
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Biosidus
Zydus Cadila
Nanogen
Amega Biotech
Rhein Minapharm Biogenetics
PROBIOMED
3sbio
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Interferon Alpha-2a Biosimilar consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Interferon Alpha-2a Biosimilar market by identifying its various subsegments.
Focuses on the key global Interferon Alpha-2a Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interferon Alpha-2a Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interferon Alpha-2a Biosimilar submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Interferon Alpha-2a Biosimilar Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Interferon Alpha-2a Biosimilar Consumption 2014-2024
- 2.1.2 Interferon Alpha-2a Biosimilar Consumption CAGR by Region
- 2.2 Interferon Alpha-2a Biosimilar Segment by Type
- 2.2.1 Long-lasting Type
- 2.2.2 Ordinary Type
- 2.3 Interferon Alpha-2a Biosimilar Consumption by Type
- 2.3.1 Global Interferon Alpha-2a Biosimilar Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Interferon Alpha-2a Biosimilar Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Interferon Alpha-2a Biosimilar Sale Price by Type (2014-2019)
- 2.4 Interferon Alpha-2a Biosimilar Segment by Application
- 2.4.1 Hepatitis C
- 2.4.2 Hepatitis B
- 2.4.3 Other
- 2.5 Interferon Alpha-2a Biosimilar Consumption by Application
- 2.5.1 Global Interferon Alpha-2a Biosimilar Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Interferon Alpha-2a Biosimilar Value and Market Share by Application (2014-2019)
- 2.5.3 Global Interferon Alpha-2a Biosimilar Sale Price by Application (2014-2019)
3 Global Interferon Alpha-2a Biosimilar by Players
- 3.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Players
- 3.1.1 Global Interferon Alpha-2a Biosimilar Sales by Players (2017-2019)
- 3.1.2 Global Interferon Alpha-2a Biosimilar Sales Market Share by Players (2017-2019)
- 3.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Players
- 3.2.1 Global Interferon Alpha-2a Biosimilar Revenue by Players (2017-2019)
- 3.2.2 Global Interferon Alpha-2a Biosimilar Revenue Market Share by Players (2017-2019)
- 3.3 Global Interferon Alpha-2a Biosimilar Sale Price by Players
- 3.4 Global Interferon Alpha-2a Biosimilar Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Interferon Alpha-2a Biosimilar Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Interferon Alpha-2a Biosimilar Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Interferon Alpha-2a Biosimilar by Regions
- 4.1 Interferon Alpha-2a Biosimilar by Regions
- 4.1.1 Global Interferon Alpha-2a Biosimilar Consumption by Regions
- 4.1.2 Global Interferon Alpha-2a Biosimilar Value by Regions
- 4.2 Americas Interferon Alpha-2a Biosimilar Consumption Growth
- 4.3 APAC Interferon Alpha-2a Biosimilar Consumption Growth
- 4.4 Europe Interferon Alpha-2a Biosimilar Consumption Growth
- 4.5 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption Growth
5 Americas
- 5.1 Americas Interferon Alpha-2a Biosimilar Consumption by Countries
- 5.1.1 Americas Interferon Alpha-2a Biosimilar Consumption by Countries (2014-2019)
- 5.1.2 Americas Interferon Alpha-2a Biosimilar Value by Countries (2014-2019)
- 5.2 Americas Interferon Alpha-2a Biosimilar Consumption by Type
- 5.3 Americas Interferon Alpha-2a Biosimilar Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Interferon Alpha-2a Biosimilar Consumption by Countries
- 6.1.1 APAC Interferon Alpha-2a Biosimilar Consumption by Countries (2014-2019)
- 6.1.2 APAC Interferon Alpha-2a Biosimilar Value by Countries (2014-2019)
- 6.2 APAC Interferon Alpha-2a Biosimilar Consumption by Type
- 6.3 APAC Interferon Alpha-2a Biosimilar Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Interferon Alpha-2a Biosimilar by Countries
- 7.1.1 Europe Interferon Alpha-2a Biosimilar Consumption by Countries (2014-2019)
- 7.1.2 Europe Interferon Alpha-2a Biosimilar Value by Countries (2014-2019)
- 7.2 Europe Interferon Alpha-2a Biosimilar Consumption by Type
- 7.3 Europe Interferon Alpha-2a Biosimilar Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Interferon Alpha-2a Biosimilar by Countries
- 8.1.1 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Interferon Alpha-2a Biosimilar Value by Countries (2014-2019)
- 8.2 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Type
- 8.3 Middle East & Africa Interferon Alpha-2a Biosimilar Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Interferon Alpha-2a Biosimilar Distributors
- 10.3 Interferon Alpha-2a Biosimilar Customer
11 Global Interferon Alpha-2a Biosimilar Market Forecast
- 11.1 Global Interferon Alpha-2a Biosimilar Consumption Forecast (2019-2024)
- 11.2 Global Interferon Alpha-2a Biosimilar Forecast by Regions
- 11.2.1 Global Interferon Alpha-2a Biosimilar Forecast by Regions (2019-2024)
- 11.2.2 Global Interferon Alpha-2a Biosimilar Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Interferon Alpha-2a Biosimilar Forecast by Type
- 11.8 Global Interferon Alpha-2a Biosimilar Forecast by Application
12 Key Players Analysis
- 12.1 Roche
- 12.1.1 Company Details
- 12.1.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.1.3 Roche Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Roche News
- 12.2 Biosidus
- 12.2.1 Company Details
- 12.2.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.2.3 Biosidus Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Biosidus News
- 12.3 Zydus Cadila
- 12.3.1 Company Details
- 12.3.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.3.3 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Zydus Cadila News
- 12.4 Nanogen
- 12.4.1 Company Details
- 12.4.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.4.3 Nanogen Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Nanogen News
- 12.5 Amega Biotech
- 12.5.1 Company Details
- 12.5.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.5.3 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Amega Biotech News
- 12.6 Rhein Minapharm Biogenetics
- 12.6.1 Company Details
- 12.6.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Rhein Minapharm Biogenetics News
- 12.7 PROBIOMED
- 12.7.1 Company Details
- 12.7.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.7.3 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 PROBIOMED News
- 12.8 3sbio
- 12.8.1 Company Details
- 12.8.2 Interferon Alpha-2a Biosimilar Product Offered
- 12.8.3 3sbio Interferon Alpha-2a Biosimilar Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 3sbio News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Interferon Alpha-2a Biosimilar . Industry analysis & Market Report on Interferon Alpha-2a Biosimilar is a syndicated market report, published as Global Interferon Alpha-2a Biosimilar Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Interferon Alpha-2a Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
